Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human AVPR1B ELISA Kit (AC2526)
Cat.#: ASET-1115
Specifications
Description Human AVPR1B ELISA Kit allows for the in vitro quantitative determination of human AVPR1B concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1062 Human MMP24 ELISA Kit (AC2473) Quantitative inquiry ASET-2115 Mouse ERK2 ELISA Kit (AC3526) Quantitative inquiry ASET-1839 Human Chordin ELISA Kit (AC3250) Quantitative inquiry ASET-1662 Rat TIMP1 ELISA Kit (AC3073) Quantitative inquiry ASET-1885 Human Neuroligin 3 ELISA Kit (AC3296) Quantitative inquiry ASET-1582 Canine beta Nerve Growth Factor ELISA Kit (AC2993) Quantitative inquiry ASET-1129 Rat CNTF ELISA Kit (AC2540) Quantitative inquiry ASET-2321 Mouse Dehydroepiandrosterone ELISA Kit (AC3732) Quantitative inquiry ASET-2379 Human EN2 ELISA Kit (AC3790) Quantitative inquiry ASET-1341 Chicken Acetylcholinesterase ELISA Kit (AC2752) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket